Raffa Wealth Management’s Adial Pharmaceuticals ADIL Stock Holding History

Raffa Wealth Management’s Portfolio ADIL Stock Details ADIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$212	Hold	83	–	–	﹤0.01%	1256
2026 Q1	$149	Sell	83 -1	-1%	-$4	﹤0.01%	1223
2025 Q4	$460	Hold	84	–	–	﹤0.01%	1079
2025 Q3	$740	Hold	84	–	–	﹤0.01%	966
2025 Q2	$633	Hold	84	–	–	﹤0.01%	953
2025 Q1	$1.33K	Hold	84	–	–	﹤0.01%	744
2024 Q4	$2.11K	Hold	84	–	–	﹤0.01%	658
2024 Q3	$2.09K	Hold	84	–	–	﹤0.01%	628
2024 Q2	$2.41K	Hold	84	–	–	﹤0.01%	677
2024 Q1	$2.78K	Hold	84	–	–	﹤0.01%	627
2023 Q4	$3.89K	Hold	84	–	–	﹤0.01%	445
2023 Q3	$5.82K	Hold	84	–	–	﹤0.01%	357
2023 Q2	$10.9K	Hold	84	–	–	﹤0.01%	274
2023 Q1	$18.3K	Hold	84	–	–	0.01%	225
2022 Q4	$11.3K	Hold	84	–	–	﹤0.01%	268
2022 Q3	$18.3K	Hold	84	–	–	0.01%	211
2022 Q2	$70.1K	Buy	84 +17	+25%	+$15.4K	0.03%	111
2022 Q1	$84.1K	Hold	67	–	–	0.03%	101
2021 Q4	$113K	Hold	67	–	–	0.04%	84
2021 Q3	$180K	Hold	67	–	–	0.06%	50
2021 Q2	$107K	Hold	67	–	–	0.04%	71
2021 Q1	$101K	Hold	67	–	–	0.04%	95
2020 Q4	$71.1K	Hold	67	–	–	0.03%	103
2020 Q3	$93.3K	Hold	67	–	–	0.04%	87
2020 Q2	$58.2K	Hold	67	–	–	0.02%	104
2020 Q1	$54.4K	Hold	67	–	–	0.02%	100
2019 Q4	$101K	Hold	67	–	–	0.04%	94
2019 Q3	$63.2K	Buy	+67	New	+$71.3K	0.02%	113
2019 Q2	–	Sell	-67	Closed	-$144K	–	742
2019 Q1	$144K	Buy	+67	New	+$200K	0.06%	69

Other funds holding ADIL

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

MCM

Manchester Capital Management Manchester, Vermont $768M AUM 29.32% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Raffa Wealth Management's ADIL Position: Q2 2026 in Review

Raffa Wealth Management held its Adial Pharmaceuticals (ADIL) position steady in Q2 2026 at 83 shares worth $212. The position accounts for ﹤0.01% of the portfolio, ranked #1256.

Raffa Wealth Management first reported a position in ADIL in Q1 2019 and has held it in 29 quarters since. The position peaked at $180K in Q3 2021. 17 funds tracked by Wall St. Rank hold ADIL as of Q2 2026.

Raffa Wealth Management held 83 shares of Adial Pharmaceuticals worth $212 as of Q2 2026.
Raffa Wealth Management left its Adial Pharmaceuticals share count unchanged in Q2 2026.
Adial Pharmaceuticals made up ﹤0.01% of Raffa Wealth Management's portfolio in Q2 2026, its #1256 holding.
Raffa Wealth Management first reported a position in Adial Pharmaceuticals in Q1 2019 and has held it in 29 quarters since.
Raffa Wealth Management's Adial Pharmaceuticals position peaked at $180K in Q3 2021.
17 funds tracked by Wall St. Rank held Adial Pharmaceuticals as of Q2 2026.

Based on Raffa Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.